101 related articles for article (PubMed ID: 10677630)
1. Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions.
Crain SM; Shen K
Brain Res; 2000 Feb; 856(1-2):227-35. PubMed ID: 10677630
[TBL] [Abstract][Full Text] [Related]
2. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Shen KF; Crain SM
Brain Res; 1997 May; 757(2):176-90. PubMed ID: 9200746
[TBL] [Abstract][Full Text] [Related]
3. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence.
Shen KF; Crain SM
Brain Res; 2001 Nov; 919(1):20-30. PubMed ID: 11689159
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice.
Crain SM; Shen KF
Brain Res; 2004 Jan; 995(2):260-6. PubMed ID: 14672816
[TBL] [Abstract][Full Text] [Related]
5. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability.
Crain SM; Shen KF
Pain; 2000 Feb; 84(2-3):121-31. PubMed ID: 10666516
[TBL] [Abstract][Full Text] [Related]
7. GM1 ganglioside-induced modulation of opioid receptor-mediated functions.
Crain SM; Shen KF
Ann N Y Acad Sci; 1998 Jun; 845():106-25. PubMed ID: 9668346
[TBL] [Abstract][Full Text] [Related]
8. Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.
Crain SM; Shen KF
Brain Res; 1996 Nov; 741(1-2):275-83. PubMed ID: 9001733
[TBL] [Abstract][Full Text] [Related]
9. Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential.
Shen KF; Crain SM; Ledeen RW
Brain Res; 1991 Sep; 559(1):130-8. PubMed ID: 1685937
[TBL] [Abstract][Full Text] [Related]
10. The role of GM1 ganglioside in regulating excitatory opioid effects.
Wu G; Lu ZH; Wei TJ; Howells RD; Christoffers K; Ledeen RW
Ann N Y Acad Sci; 1998 Jun; 845():126-38. PubMed ID: 9668347
[TBL] [Abstract][Full Text] [Related]
11. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.
Crain SM; Shen KF
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10540-4. PubMed ID: 7479836
[TBL] [Abstract][Full Text] [Related]
12. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions.
Crain SM; Shen KF
Trends Pharmacol Sci; 1998 Sep; 19(9):358-65. PubMed ID: 9786023
[TBL] [Abstract][Full Text] [Related]
13. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia.
Crain SM; Shen KF
Brain Res; 2001 Jan; 888(1):75-82. PubMed ID: 11146054
[TBL] [Abstract][Full Text] [Related]
14. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
Urca G; Yitzhaky J; Frenk H
Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
[TBL] [Abstract][Full Text] [Related]
15. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside.
Crain SM; Shen KF
Brain Res; 1992 Mar; 575(1):13-24. PubMed ID: 1324084
[TBL] [Abstract][Full Text] [Related]
16. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone.
Crain SM; Shen KF
Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459
[TBL] [Abstract][Full Text] [Related]
17. Cholera toxin-B subunit blocks excitatory effects of opioids on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions.
Shen KF; Crain SM
Brain Res; 1990 Oct; 531(1-2):1-7. PubMed ID: 1981160
[TBL] [Abstract][Full Text] [Related]
18. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.
Crain SM; Shen KF
J Pharmacol Exp Ther; 1992 Jan; 260(1):182-6. PubMed ID: 1731037
[TBL] [Abstract][Full Text] [Related]
19. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
Juni A; Klein G; Kest B
Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation.
Yoburn BC; Sierra V; Lutfy K
Brain Res; 1990 Oct; 529(1-2):143-8. PubMed ID: 2178026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
